ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VAL Valirx Plc

3.35
0.05 (1.52%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Valirx Plc LSE:VAL London Ordinary Share GB00BLH13C52 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 1.52% 3.35 3.30 3.40 3.35 3.30 3.30 164,059 15:18:31
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -2.37M -0.0262 -1.28 3.02M
Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 3.30p. Over the last year, Valirx shares have traded in a share price range of 3.25p to 14.75p.

Valirx currently has 90,174,156 shares in issue. The market capitalisation of Valirx is £3.02 million. Valirx has a price to earnings ratio (PE ratio) of -1.28.

Valirx Share Discussion Threads

Showing 27201 to 27223 of 29350 messages
Chat Pages: Latest  1090  1089  1088  1087  1086  1085  1084  1083  1082  1081  1080  1079  Older
DateSubjectAuthorDiscuss
22/8/2023
15:07
Thought you had gone missing in action.

You buying down here as you said I’d be lucky to get in at double figures a few weeks back.

Surely a no brainer for you.

francoismyname
22/8/2023
14:56
Still here 4p Franco await just like you.
412069
22/8/2023
14:29
May get to my 4.5p placing prediction price off it’s own steam at this rate .

Anyone seen 412 ??

francoismyname
22/8/2023
14:08
The only reason to take part in any placing here is to average down thinking it will move up later and you can get out break even. That imho is a fools errand as you will simply loose more money.

However as I have seen many times before placings are got away because the price has already been agreed and the ones taking part are already shorting their allocation to close off at a profit in the placing.

I wouldn't touch this stock with a barge pole personally

dope007
22/8/2023
13:19
@porky. Yes i agree. Aptamer substantially better roi 👏
jasonpugh
22/8/2023
13:01
@Livedata
I invest in multiple penny share plays as a small percentage of my portfolio, some work out some don't. With this one i have done my homework as best i can doesn't mean I'm right, do your own research.

However, my view remains that securing working capital in this market can only come at a significant discount, we are seeing that all over, that's IF the market will support VAL yet again.

After 15 raises, three 125:1 share consolidations, five raises under Suzy and a sixth due any moment my view is that SH now need something more than a JAM tomorrow story to support more cash being chucked at this but i could be wrong? I also think they need to make material steps to cut cash burn and need to offload the dead wood from the BOD.

What i do know is that on L2 currently CNKS the joint brokers will only take stock off you at 4.5p. Looks to me that this will go to 5p shortly and IF placing gets supported for another £1m will drop to 3 to 3.5p BUT that is ONLY if they can secure support.

Will Adam chuck more cash at this to pay the BODs wages, really wouldn't blame the guy if he calls time on it....

porky9
22/8/2023
12:03
It's amazing how Porky seems to know everything but lost it all in DDDD
livedata21
22/8/2023
11:34
Not sure who you guys think Adam could sell a substantial number of shares to in a low volume market for Val a very weak share price Stella suporting a raise together with her extensive contacts is surely the only way a decent amount of capital could possibly be raised & she made her position very clear,publicly -so Suzy needs to acquire some very special loaves & fish.
base7
22/8/2023
11:24
As it stands Turner Pope clients have supported both the July 22 raise and the Jan 23 raise. In this market i really think it will be a tough call for the same client base to support a Sept 23 raise without heavy discount.

I will be genuinely impressed if VAL can secure another £1m of working capital at 3.5p - even PYC had to give a 50% discount just to secure £350k and they are doing £700k of revenue. VAL is yet to declare ANY revenue other than whatever the 3 mth lab contract came in at.

But at the end of the day, would you back a 3.5p placing to raise another £1m knowing that all you are doing is extending the working capital cash runway by 4 months???

Adam will need to make some big decisions shortly. He is holding 7.750m of stock here and they have not treated him well frankly. They have treated him with utter contempt but without doubt they will needing him soon that's for sure and I know what my answer would be.

porky9
22/8/2023
10:02
@JasonPugh
1. Nick is a prolific investor he can buy what he likes when he likes. On paper Aptamer is the better play. For one thing its well funded. How they trade forwards is something else and that’s down to the management. If you buy penny shares you need to spread your portfolio. There is nothing sinister in Nick buying into Aptamer, that’s his business.
2. Valirx need to raise money for working capital before the year is out which is a challenge in the current market. IF they secure support it can only come at a discount.
3. Adam has shown no signs of selling VAL but from a pure business perspective he would be mad not to hedge his portfolio by at least selling half VAL and buying half Aptamer where he is a director and can influence direction - that’s business sense.
4. If Adam then wants to buy back into VAL he can do so to support their discounted placing - that’s logical to me although personally I wouldn’t support the placing at vAL without material board changes but that’s my own preference others disagree.
5. As for shorting, I don’t believe that, much better plays to short if that’s your call this isn’t one of them. Once Turner Pope start talking to existing investors to establish if support can be secured that’s when the share price will start dropping and when vAL will need some pumping news out to bolster the share price

Frankly, as I say nothing sinister going on imo. But for what it’s worth imo they will need to call on Adam to get the placement supported he probably would need to chip in £500k and from a business perspective that cash would do better in Aptamer plus the existing BOD would need to dig deep themselves which they won’t want to do either.

It will get interesting imo but for different reasons to yours, markets are just ugly at the current time especially this sector, you have to pick your plays carefully and Park emotion.

porky9
22/8/2023
09:42
The placing will be soon upon Val.

Can’t run from it forever.

francoismyname
22/8/2023
07:15
A nuclear financial bomb about to drop on valirx.
With 201 shortly to be terminated with theoremrx as patent useless a bigger story is about to develop.

Adam Hargreaves was recently appointed to aptamer board and he was also given a hugh incentive from suzy pre agm to secure his vote (will become apparent very soon). Adam and slater are thick as thieves. Slater just bought a chunk of aptamer (rns yesterday) and very soon adam Hargreaves will start offloading his valirx shares and will short valirx with slater and will director buy big in APTAMER. This synergetic effect will recoup adams losses (average 22p valirx sp). Obviously this is my opinion and advise others to do their own due diligence. DYOR.

jasonpugh
18/8/2023
12:32
As disappointing as Suzys performance has been regarding the legacy projects & especially 201 & the Tx debacle including her inability to tell the truth -however, under George & Mildred Val the lights would have gone out years ago & their irritation & crticism of the current Board arose entirely as they were unable to buy back the IP of a failed Val cheaply - all IMHO !
base7
18/8/2023
11:07
Part 2. I put the same question to Satu vainikka who knows more about 201 than anyone.
Reply. “Jason, i dont think it looks promising at the moment. The more i see V company, the more i want to go there and discuss. But as said the shareholders got what they wanted”.
Satu is still a shareholder but is alarmed at the procrastination of suzy and kevin and theoromrx DYOR

jasonpugh
18/8/2023
07:37
Part 1. I know a lot of people dont like George Morris however his knowledge on 201 is vastly superior to suzys hence latest comments ..
Jason “do you think that Theoremrx will get the cash raise for 201?”

George “No and no need the IPR is gone valirx have squandered it all and the patients are over. End of so shy pay fir something you can have for nothing ? Just needing the expertise to progress it and they dint have that anymore than valirx have”
Not my spelling mistakes 🫣
DYOR

jasonpugh
17/8/2023
21:14
On a lighter note. Slater the slug bought 12.5 mill of aptamer for a handsome roi of minus 40%. 🫣😳
jasonpugh
17/8/2023
12:26
Why would I want to join a mobile group of 4-6 people who are all nursing losses, fully invested but want to feel better for it as part of an echo chamber? Absolutely pointless.

At least debating here the investment gets discussed good or bad

porky9
16/8/2023
21:06
Telegram group

t.me/valirxgroup or search #VAL in the telegram search bar.

Appreciate it if Porky and Pugh would steer clear.

sidalmighty
16/8/2023
08:58
@francoismyname.
Totally agree
201 investors have been misled.
301. Moved from Japanese company to own lab. Lol
401. Billion year wait for antipsychotic drug. Lol.
Bc201. 🫣
CLX001. Mm
Investable? DYOR 😳

jasonpugh
16/8/2023
08:54
250k sales this morning early doors.

They know !!!!

francoismyname
16/8/2023
06:30
and I thought something interesting...
same old Porky and Co blabbering.
still cant get your motives Porky!

qnq
16/8/2023
05:48
@Wulber
Agree that IF THX officially stated they can't complete that VAL would then be forced to report it confirming same to the market.

However, you are quite wrong that "otherwise it would simply lapse" and this is because when THX failed to meet three extended time lines to complete and didn't pay lab fees, rather than VAL end the relationship at that point they simply announced to the market that they had removed any future timelines and the deal still remained exclusive.

Since that point Suzy was posting "confident and unconcerned" messages on social media and constantly trying to reassure shareholders the "deal will get done"

Put simply, the deal wont get done BUT its not in VAL's interests to announce that to the market with a placement pending, they need to put out as much positive spin as they can to try and support the share price so that when the discount is applied they can still extract as much cash as possible and get it over the line.

Its perfectly possible that AFTER the placing they may come clean and confirm the deal is going nowhere and exclusivity has been removed but for now its much better to retain hopium and say nothing and keep kicking it into the long grass.

porky9
15/8/2023
18:16
Porky and Jason, an RNS cancel update for THX and 201 would only happen IF all bets are off and THX confirm to the VAL then they have to RNS. Otherwise it would simply lapse and no need for a RNS.Make your own mind up?
wulber
Chat Pages: Latest  1090  1089  1088  1087  1086  1085  1084  1083  1082  1081  1080  1079  Older

Your Recent History

Delayed Upgrade Clock